{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:13:18Z","timestamp":1770336798273,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.lungcan.2025.108877","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:21:55Z","timestamp":1766017315000},"page":"108877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Locoregional therapies in advanced and recurrent pleural mesothelioma: A systematic review"],"prefix":"10.1016","volume":"211","author":[{"given":"Paolo","family":"Ambrosini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7447-2519","authenticated-orcid":false,"given":"Thierry","family":"Berghmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7169-5343","authenticated-orcid":false,"given":"Mario","family":"Occhipinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Durieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-8821","authenticated-orcid":false,"given":"Paul Van","family":"Schil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7607-1863","authenticated-orcid":false,"given":"Arnaud","family":"Scherpereel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7159-7869","authenticated-orcid":false,"given":"Andrea Riccardo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1653-3544","authenticated-orcid":false,"given":"Mariana","family":"Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.lungcan.2025.108877_b0005","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.21037\/tlcr.2019.11.11","article-title":"Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted\/banned asbestos use","volume":"9","author":"Alpert","year":"2020","journal-title":"Transl Lung Cancer Res."},{"issue":"8","key":"10.1016\/j.lungcan.2025.108877_b0010","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108877_b0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-2600(24)00119-X","article-title":"Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial","volume":"12","author":"Lim","year":"2024","journal-title":"Lancet Respir. Med."},{"issue":"9","key":"10.1016\/j.lungcan.2025.108877_b0020","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1016\/S1470-2045(17)30459-X","article-title":"Radiotherapy for the treatment of malignant pleural mesothelioma","volume":"18","author":"De Perrot","year":"2017","journal-title":"Lancet Oncol."},{"issue":"19","key":"10.1016\/j.lungcan.2025.108877_b0025","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.3390\/jcm13195837","article-title":"Malignant pleural mesothelioma: A comprehensive review","volume":"13","author":"Jain","year":"2024","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.lungcan.2025.108877_b0030","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1200\/JCO.22.02542","article-title":"Phase III Study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"41","author":"Vogelzang","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"28","key":"10.1016\/j.lungcan.2025.108877_b0035","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"Van Meerbeeck","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"10026","key":"10.1016\/j.lungcan.2025.108877_b0040","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): A randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"issue":"10272","key":"10.1016\/j.lungcan.2025.108877_b0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"issue":"10419","key":"10.1016\/j.lungcan.2025.108877_b0050","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0140-6736(23)01613-6","article-title":"Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: A phase 3, open-label, randomised controlled trial","volume":"402","author":"Chu","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lungcan.2025.108877_b0055","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.annonc.2024.12.014","article-title":"A randomised phase III study of bevacizumab and carboplatin\u2013pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial","volume":"36","author":"Felip","year":"2025","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108877_b0060","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108877_b0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/curroncol32020075","article-title":"Oligometastatic NSCLC: Current Perspectives and Future challenges","volume":"32","author":"Torresan","year":"2025","journal-title":"Curr. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108877_b0070","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s12029-022-00900-5","article-title":"Oligometastatic colorectal cancer: A review of definitions and patient selection for local therapies","volume":"54","author":"Miller","year":"2023","journal-title":"J. Gastrointest. Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2025.108877_b0075","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: The ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108877_b0080","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jtcvs.2013.07.012","article-title":"Clinical indications and results after chest wall resection for recurrent mesothelioma","volume":"146","author":"Burt","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2025.108877_b0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.lungcan.2021.02.033","article-title":"Managing oligoprogressive malignant pleural mesothelioma with stereotactic body radiation therapy","volume":"157","author":"Barsky","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2025.108877_b0090","first-page":"9","article-title":"Stereotactic body radiation therapy (SBRT) as salvage therapy for oligorecurrent pleural mesothelioma after multi-modality therapy.","author":"Schr\u00f6der","year":"2019","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108877_b0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.annonc.2021.11.005","article-title":"Malignant pleural mesothelioma: ESMO clinical Practice guidelines for diagnosis, treatment and follow-up\u2606","volume":"33","author":"Popat","year":"2022","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108877_b0100","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00953-2019","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma","volume":"55","author":"Scherpereel","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lungcan.2025.108877_b0105","doi-asserted-by":"crossref","unstructured":"Kindler HL, Ismaila N, Bazhenova L, et al. Treatment of Pleural Mesothelioma: ASCO Guideline Update. J Clin Oncol. Published online March 10, 2025. doi:10.1200\/JCO-24-02425.","DOI":"10.1200\/OP-25-00035"},{"key":"10.1016\/j.lungcan.2025.108877_b0110","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"n71","author":"Page","year":"2021","journal-title":"BMJ. Published Online March 29"},{"key":"10.1016\/j.lungcan.2025.108877_b0115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J. Clin. Epidemiol."},{"issue":"10","key":"10.1016\/j.lungcan.2025.108877_b0120","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth."},{"issue":"9","key":"10.1016\/j.lungcan.2025.108877_b0125","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1177\/0218492316674861","article-title":"Chest wall resection for mesothelioma recurrence after surgery","volume":"24","author":"Bertoglio","year":"2016","journal-title":"Asian Cardiovasc. Thorac. Ann."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108877_b0130","first-page":"e241","article-title":"Cerebral metastasis of a malignant pleural mesothelioma: A case report and review of the literature","volume":"7","author":"Chari","year":"2015","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.lungcan.2025.108877_b0135","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.arbres.2017.03.011","article-title":"Deferred locoregional recurrence of pleural mesothelioma","volume":"53","author":"Garc\u00eda-G\u00f3mez","year":"2017","journal-title":"Arch Bronconeumol Engl Ed."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108877_b0140","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/pin.12003","article-title":"The recurrence of malignant pleural mesothelioma 14 years after extrapleural pneumonectomy: possible histological transformation","volume":"62","author":"Kinoshita","year":"2012","journal-title":"Pathol. Int."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108877_b0145","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/ejcts\/ezr263","article-title":"Cyberknife radiosurgery for focal paravertebral recurrence after radical pleurectomy\/decortication in malignant pleural mesothelioma","volume":"41","author":"Lang-Lazdunski","year":"2012","journal-title":"Eur J Cardio-Thorac Surg off J Eur Assoc Cardio-Thorac Surg."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108877_b0150","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/ans.13072","article-title":"Iterative surgery for recurrent malignant pleural mesothelioma in long-term survivor","volume":"87","author":"Leuzzi","year":"2017","journal-title":"ANZ J. Surg."},{"key":"10.1016\/j.lungcan.2025.108877_b0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.xjtc.2020.05.019","article-title":"Successful treatment of a patient with oligometastatic mesothelioma to the brain","volume":"3","author":"Li","year":"2020","journal-title":"JTCVS Tech."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108877_b0160","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1016\/j.athoracsur.2017.12.039","article-title":"Radiofrequency ablation effectively treated focal recurrence of mesothelioma","volume":"105","author":"Nakamura","year":"2018","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.lungcan.2025.108877_b0165","article-title":"Salvage debulking surgery and hyperthermic intrathoracic chemotherapy for massive recurrent mesothelioma in the mediastinum","volume":"35(1):ivac034","author":"Poon","year":"2022","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"issue":"30","key":"10.1016\/j.lungcan.2025.108877_b0170","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/1759-7714.15095","article-title":"En bloc resection of the recurrent pleural mesothelioma and reconstruction of the chest wall after immunotherapy: A case report","volume":"14","author":"Qin","year":"2023","journal-title":"Thorac Cancer."},{"key":"10.1016\/j.lungcan.2025.108877_b0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/1742-6413.132984","article-title":"Metastatic mesothelioma to the thyroid","volume":"11","author":"Rao","year":"2014","journal-title":"CytoJournal"},{"issue":"23s","key":"10.1016\/j.lungcan.2025.108877_b0180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2217\/fon-2016-0330","article-title":"Intensity-modulated radiotherapy for relapsed malignant pleural mesothelioma","volume":"12","author":"Spatola","year":"2016","journal-title":"Future Oncol Lond Engl."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108877_b0185","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/omcr\/omu064","article-title":"Localized malignant pleural mesothelioma with renal metastasis","volume":"2015","author":"Zardawi","year":"2015","journal-title":"Oxf Med Case Rep."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108877_b0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jvir.2016.09.027","article-title":"Percutaneous cryoablation for the treatment of recurrent malignant pleural mesothelioma: Safety, early-term efficacy, and predictors of local recurrence","volume":"28","author":"Abtin","year":"2017","journal-title":"J Vasc Interv Radiol JVIR."},{"key":"10.1016\/j.lungcan.2025.108877_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2020.11.022","article-title":"Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma","volume":"152","author":"Ghirardelli","year":"2021","journal-title":"Lung Cancer Amst Neth."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108877_b0200","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1016\/j.prro.2024.05.004","article-title":"Stereotactic body radiation therapy for oligoprogressive pleural mesothelioma: Fine-Tuning the optimal doses","volume":"14","author":"Ghirardelli","year":"2024","journal-title":"Pract. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108877_b0205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1759-7714.2012.00138.x","article-title":"Treatment for recurrence after extrapleural pneumonectomy for malignant pleural mesothelioma: A single institution experience","volume":"4","author":"Okamoto","year":"2013","journal-title":"Thorac Cancer."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108877_b0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.athoracsur.2009.09.028","article-title":"Second surgery for recurrence of malignant pleural mesothelioma after extrapleural pneumonectomy","volume":"89","author":"Politi","year":"2010","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.lungcan.2025.108877_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110057","article-title":"Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma","volume":"191","author":"Shin","year":"2024","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2025.108877_b0220","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.21037\/jtd.2016.07.55","article-title":"Validation of EORTC and CALGB prognostic models in surgical patients submitted to diagnostic, palliative or curative surgery for malignant pleural mesothelioma","volume":"8","author":"Sandri","year":"2016","journal-title":"J. Thorac. Dis."},{"issue":"8","key":"10.1016\/j.lungcan.2025.108877_b0225","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","article-title":"Biological mechanisms and clinical significance of BAP1 mutations in human cancer","volume":"10","author":"Carbone","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.lungcan.2025.108877_b0230","doi-asserted-by":"crossref","first-page":"S1907","DOI":"10.1016\/S0167-8140(24)01658-X","article-title":"1215: Oligometastatic mesothelioma treated with ablative radiotherapy (OMAR): Multi-institutional database","volume":"194","author":"Franceschini","year":"2024","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2025.108877_b0235","doi-asserted-by":"crossref","first-page":"S1768","DOI":"10.1016\/S0167-8140(24)02847-0","article-title":"2679: Role of stereotactic radiotherapy in oligo-recurrence of pleural mesothelioma","volume":"194","author":"Revelant","year":"2024","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2025.108877_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104676","article-title":"Consolidative radiotherapy in oligometastatic and oligoprogressive NSCLC: A systematic review","volume":"210","author":"Hasan","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108877_b0245","article-title":"A phase 1 safety study of avelumab plus stereotactic body radiation therapy in malignant pleural mesothelioma","volume":"4","author":"Rimner","year":"2023","journal-title":"JTO Clin Res Rep."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108877_b0250","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.thorsurg.2004.06.006","article-title":"Patterns of failure following surgical resection for malignant pleural mesothelioma","volume":"14","author":"J\u00e4nne","year":"2004","journal-title":"Thorac. Surg. Clin."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108877_b0255","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.athoracsur.2019.11.048","article-title":"Clinical outcomes with recurrence after pleurectomy\/decortication for malignant pleural mesothelioma","volume":"109","author":"Nakamura","year":"2020","journal-title":"Ann. Thorac. Surg."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108877_b0260","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jtcvs.2014.10.128","article-title":"Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma","volume":"149","author":"Baldini","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108877_b0265","article-title":"Incidence and outcomes of brain metastasis in pleural mesothelioma in the era of immunotherapy","volume":"6","author":"Stalker","year":"2025","journal-title":"JTO Clin Res Rep."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108877_b0270","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.athoracsur.2014.12.077","article-title":"Intrapleural photodynamic therapy for mesothelioma: What place and which future?","volume":"99","author":"Munck","year":"2015","journal-title":"Ann. Thorac. Surg."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108877_b0275","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.athoracsur.2012.02.009","article-title":"Radical Pleurectomy and Intraoperative Photodynamic Therapy for Malignant Pleural Mesothelioma","volume":"93","author":"Friedberg","year":"2012","journal-title":"Ann. Thorac. Surg."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950022500769X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950022500769X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T17:22:28Z","timestamp":1769448148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016950022500769X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":55,"alternative-id":["S016950022500769X"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108877","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Locoregional therapies in advanced and recurrent pleural mesothelioma: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108877"}}